Close Menu
TechBrunchTechBrunch
  • Home
  • AI
  • Apps
  • Crypto
  • Security
  • Startups
  • TechCrunch
  • Venture

Subscribe to Updates

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated!

What's Hot

iOS 19: All the rumor changes that Apple could bring to the new operating system

June 7, 2025

The Trump administration is aiming for Biden and Obama's cybersecurity rules

June 7, 2025

WWDC 2025: What to expect from this year's meeting

June 7, 2025
Facebook X (Twitter) Instagram
TechBrunchTechBrunch
  • Home
  • AI

    OpenAI seeks to extend human lifespans with the help of longevity startups

    January 17, 2025

    Farewell to the $200 million woolly mammoth and TikTok

    January 17, 2025

    Nord Security founder launches Nexos.ai to help enterprises move AI projects from pilot to production

    January 17, 2025

    Data proves it remains difficult for startups to raise capital, even though VCs invested $75 billion in the fourth quarter

    January 16, 2025

    Apple suspends AI notification summaries for news after generating false alerts

    January 16, 2025
  • Apps

    iOS 19: All the rumor changes that Apple could bring to the new operating system

    June 7, 2025

    WWDC 2025: What to expect from this year's meeting

    June 7, 2025

    Trump Mask feud was perfect for X and jumped on the app store chart

    June 6, 2025

    iOS 19: All the rumor changes that Apple could bring to the new operating system

    June 6, 2025

    WWDC 2025: What to expect from this year's meeting

    June 6, 2025
  • Crypto

    xNotify Polymarket as partner in the official forecast market

    June 6, 2025

    Circle IPOs are giving hope to more startups waiting to be published to more startups

    June 5, 2025

    GameStop bought $500 million in Bitcoin

    May 28, 2025

    Vote for the session you want to watch in 2025

    May 26, 2025

    Save $900 + 90% from 2 tickets to destroy 2025 in the last 24 hours

    May 25, 2025
  • Security

    The Trump administration is aiming for Biden and Obama's cybersecurity rules

    June 7, 2025

    After data is wiped out, Kiranapro co-founders cannot rule out external hacks

    June 7, 2025

    Humanity appoints national security experts to governing trusts

    June 6, 2025

    Italian lawmakers say Italy used spyware to target immigrant activists' mobile phones, but not for journalists

    June 6, 2025

    Humanity unveils custom AI models for US national security customers

    June 5, 2025
  • Startups

    7 days left: Founders and VCs save over $300 on all stage passes

    March 24, 2025

    AI chip startup Furiosaai reportedly rejecting $800 million acquisition offer from Meta

    March 24, 2025

    20 Hottest Open Source Startups of 2024

    March 22, 2025

    Andrill may build a weapons factory in the UK

    March 21, 2025

    Startup Weekly: Wiz bets paid off at M&A Rich Week

    March 21, 2025
  • TechCrunch

    OpenSea takes a long-term view with a focus on UX despite NFT sales remaining low

    February 8, 2024

    AI will save software companies' growth dreams

    February 8, 2024

    B2B and B2C are not about who buys, but how you sell

    February 5, 2024

    It's time for venture capital to break away from fast fashion

    February 3, 2024

    a16z's Chris Dixon believes it's time to focus on blockchain use cases rather than speculation

    February 2, 2024
  • Venture

    Why investing in a growing AI startup is risky and more complicated

    June 6, 2025

    Startup Battlefield 200: Only 3 days left

    June 6, 2025

    Book all TC Stage Exhibitor Tables before ending today

    June 6, 2025

    Less than 48 hours left until display at TC at all stages

    June 5, 2025

    TC Session: AI will be on sale today at Berkeley

    June 5, 2025
TechBrunchTechBrunch

This Swedish startup wants to reduce the costs and controversy surrounding stem cell production.

TechBrunchBy TechBrunchMarch 5, 20244 Mins Read
Facebook Twitter Pinterest Telegram LinkedIn Tumblr WhatsApp Email
Share
Facebook Twitter LinkedIn Pinterest Telegram Email


With the news that the first “mini-organs” have been grown using human stem cells, this field of future biomedicine is clearly accelerating by leaps and bounds. However, harvesting stem cells is controversial, as the primary method involves harvesting stem cells during pregnancy. Now, a Swedish startup has raised VC investment to launch a new process to generate stem cells (from bone marrow donated by adult volunteers). These stem cells have been hailed as an innovative tool to alleviate and prevent a variety of medical conditions, and have reached industrial scale.

In an exclusive interview with TechCrunch, Stockholm-based Cellcolabs revealed that it has now raised $8.7 million, bringing its total funding since its founding in 2021 to $21.5 million.

To date, most stem cells have been harvested from adult stem cells or postpartum fetal tissue. Yesterday's news details how researchers at UCL and London's Great Ormond Street Hospital have extracted stem cells that have entered the amniotic fluid that surrounds children in the womb and protects them during pregnancy. did.

However, for obvious reasons, regulations limit when these fetal samples can be obtained. In countries like the United States, fetal sampling is actually completely illegal.

The clinical-stage biotech startup has raised funding from a number of investors, including Swedish investors Fredrik Osterberg and Jens von Bahr (Osterberg founded the online operator in 2006). He co-founded Evolution AB, which sells casino solutions, with Mr. von Bahr). Previous investors include Norsken Launcher, Avito founders Jonas Nordlander and Filip Engelbert. The funds will be used to expand research and development, operations and business development.

Cellcolabs originates from the pioneering stem cell research of Professor Katharina Le Brun at Stockholm's world-famous Karolinska Institutet, best known for awarding the Nobel Prize in Medicine.

Founders Per Bortelson, Maria Ranka, and impact investor Norsken teamed up with Professor Le Blanc to establish Cellcollaborative and brought on medically trained Matthias Burnou as CEO.

Cellcolabs specializes in rare and expensive mesenchymal stem cells (MSCs). According to a statement from the company, these are a type of stem cell with anti-inflammatory, regenerative, and immunomodulatory properties that “promote the healing of damaged tissue and provide immune support that reduces inflammation, which is the root cause of many diseases.” It is possible to “regulate the response.” Mesenchymal stem cells are also used in the field of longevity, as inflammation contributes to aging.

Cellcolabs claims that its process of harvesting cells from the bone marrow of healthy volunteer donors has the potential to reduce the price of MSCs by up to 90% within the next decade through large-scale production.

In an interview with TechCrunch, Bernau said: What's really interesting to me as a doctor, of course, is whether we can use cells to prevent disease. I think in many cases we can reduce the burden of disease to some extent. ”

“What we are serious about is making cells available. MSCs are very expensive and very difficult to obtain. I was given the opportunity to collaborate with one of my professors, which in a way is a privilege and a blessing.”

Burnough said the company has no competitors to his knowledge, at least on an industrial scale. However, he acknowledged that “it is very difficult to know what the Chinese are doing in this field.” French startup TreeFrog Therapeutics is also working on cell manufacturing, but its approach is to take cells from the skin or blood and “reprogram” them into stem cells. The company raised $75 million in September 2021.

“We have built what we believe to be one of the largest facilities in the world dedicated solely to the production of stem cells of this kind. We are just over 45 of us here in Stockholm. We have submitted an application to the Swedish FDA,” Bernau said.

“Anyone who is serious about doing good research and wanting to bring it to patients, we have a product to offer,” he added.

Investor Fredrik Esterberg said in a statement: With Professor Le Blanc's 25 years of research, the promising potential of mesenchymal stem cells in healthcare, and an outstanding team at his direction, Cellcolabs is well-positioned to revolutionize the field of stem cells and healthcare. ”



Source link

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related Posts

7 days left: Founders and VCs save over $300 on all stage passes

March 24, 2025

AI chip startup Furiosaai reportedly rejecting $800 million acquisition offer from Meta

March 24, 2025

20 Hottest Open Source Startups of 2024

March 22, 2025

Andrill may build a weapons factory in the UK

March 21, 2025

Startup Weekly: Wiz bets paid off at M&A Rich Week

March 21, 2025

Wayve CEO shares his key elements for scaling autonomous driving technology

March 21, 2025

Leave A Reply Cancel Reply

Top Reviews
Editors Picks

7 days left: Founders and VCs save over $300 on all stage passes

March 24, 2025

AI chip startup Furiosaai reportedly rejecting $800 million acquisition offer from Meta

March 24, 2025

20 Hottest Open Source Startups of 2024

March 22, 2025

Andrill may build a weapons factory in the UK

March 21, 2025
About Us
About Us

Welcome to Tech Brunch, your go-to destination for cutting-edge insights, news, and analysis in the fields of Artificial Intelligence (AI), Cryptocurrency, Technology, and Startups. At Tech Brunch, we are passionate about exploring the latest trends, innovations, and developments shaping the future of these dynamic industries.

Our Picks

iOS 19: All the rumor changes that Apple could bring to the new operating system

June 7, 2025

The Trump administration is aiming for Biden and Obama's cybersecurity rules

June 7, 2025

WWDC 2025: What to expect from this year's meeting

June 7, 2025

Subscribe to Updates

Subscribe to our newsletter and never miss our latest news

Subscribe my Newsletter for New Posts & tips Let's stay updated!

© 2025 TechBrunch. Designed by TechBrunch.
  • Home
  • About Tech Brunch
  • Advertise with Tech Brunch
  • Contact us
  • DMCA Notice
  • Privacy Policy
  • Terms of Use

Type above and press Enter to search. Press Esc to cancel.